ETX — E-Therapeutics Share News
0.000.00%
Last trade - 00:00- £54.93m
- £23.53m
- £0.48m
Proposed Fundraise of £28.9m and Cancellation
Exercise of Options and Issue of Equity
Business Update
Director Dealing and Issue of Equity
Brief: E-Therapeutics Says Strategic RWE Collaboration With Arcturis
Brief: E-Therapeutics Says H1 Loss After Tax £5.6 Million Versus Loss Of £3.8 Million
Interim results for the six months to 31 July 2023
Notice of Interim Results
Brief: E-Therapeutics Provides Senior Management Update
Exercise of Options and Issue of Equity
Director Dealing and Issue of Equity
Investor Presentation
Notice of Investor Presentation
Notice of AGM and Posting of Annual Report
Final results for the year ended 31 January 2023
Notification of Full Year Results Date
Exercise of Options and Issue of Equity
Director/PDMR Shareholding
Brief: E-Therapeutics Says Filing Four New Patent Applications